TabletsClinical Overview
Levosulpiride Tablets (25mg, 50mg, 75mg) is the pure levorotatory (S)-enantiomer of sulpiride, acting as a selective dopamine D2 receptor antagonist and 5-HT4 receptor agonist. In the gastrointestinal tract, it increases lower esophageal sphincter tone and accelerates gastric emptying; centrally, it modulates mood and relieves visceral pain. Indicated for functional dyspepsia (postprandial distress syndrome), diabetic gastroparesis, and gastroesophageal reflux disease unresponsive to standard prokinetics.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 20 to 30 minutes before meals with water, usually 25 mg three times daily. Swallow whole.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Somnolence, fatigue, amenorrhea, galactorrhea, gynecomastia, weight gain, abdominal cramping. Rare/Severe: Extrapyramidal symptoms (acute dystonia, parkinsonian tremors), tardive dyskinesia, and neuroleptic malignant syndrome.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in mechanical bowel obstruction, GI perforation, pheochromocytoma, and epilepsy. Avoid long-term continuous therapy without monitoring for motor or neurological side effects.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Pantoprazole 40mg (Enteric Coated) + Levosulpiride 75mg (Sustained Release) Capsules
Pantoprazole (40mg enteric-coated) and Levosulpiride (75mg sustained-release) is a potent combination of a proton pump inhibitor and a prokinetic benzamide. Pantoprazole profoundly suppresses gastric acid synthesis by blocking H+/K+-ATPase pumps. Levosulpiride is the levorotatory enantiomer of sulpiride that selectively antagonizes dopamine D2 receptors in the enteric nervous system and acts as an agonist at 5-HT4 receptors, accelerating gastric and gallbladder emptying and improving antropyloric coordination. Indicated for severe GERD refractory to conventional prokinetics, diabetic gastroparesis, and functional dyspepsia with prominent postprandial distress syndrome.
Esomeprazole 40mg (Enteric-coated) + Levosulpiride 75mg (Sustained release) Capsules
Esomeprazole (40mg enteric-coated) and Levosulpiride (75mg sustained-release) combines an S-isomer proton pump inhibitor with a central/peripheral prokinetic benzamide. Esomeprazole exerts long-lasting suppression of basal and meal-stimulated gastric acid secretion. Levosulpiride selectively blocks enteric D2 receptors and stimulates 5-HT4 receptors, dramatically improving gastric accommodation and antral motility. Indicated for severe GERD, refractory non-ulcer dyspepsia, and gastroparesis.
Levosulpiride Tablets 25mg
Levosulpiride Tablets (25mg, 50mg, 75mg) is the pure levorotatory (S)-enantiomer of sulpiride, acting as a selective dopamine D2 receptor antagonist and 5-HT4 receptor agonist. In the gastrointestinal tract, it increases lower esophageal sphincter tone and accelerates gastric emptying; centrally, it modulates mood and relieves visceral pain. Indicated for functional dyspepsia (postprandial distress syndrome), diabetic gastroparesis, and gastroesophageal reflux disease unresponsive to standard prokinetics.
Levosulpiride Tablets 75 mg
Levosulpiride Tablets (25mg, 50mg, 75mg) is the pure levorotatory (S)-enantiomer of sulpiride, acting as a selective dopamine D2 receptor antagonist and 5-HT4 receptor agonist. In the gastrointestinal tract, it increases lower esophageal sphincter tone and accelerates gastric emptying; centrally, it modulates mood and relieves visceral pain. Indicated for functional dyspepsia (postprandial distress syndrome), diabetic gastroparesis, and gastroesophageal reflux disease unresponsive to standard prokinetics.